195 related articles for article (PubMed ID: 36690660)
1. Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer.
Janacova L; Stenckova M; Lapcik P; Hrachovinova S; Bouchalova P; Potesil D; Hrstka R; Müller P; Bouchal P
Sci Rep; 2023 Jan; 13(1):1285. PubMed ID: 36690660
[TBL] [Abstract][Full Text] [Related]
2. The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers.
Tolba MF; Omar HA; Hersi F; Nunes ACF; Noreddin AM
Mol Cell Endocrinol; 2019 May; 488():79-88. PubMed ID: 30904591
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
[TBL] [Abstract][Full Text] [Related]
4. The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols.
Sak K
Drug Metab Rev; 2017 Feb; 49(1):56-83. PubMed ID: 27826992
[TBL] [Abstract][Full Text] [Related]
5. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells.
Lehmann L; Jiang L; Wagner J
Carcinogenesis; 2008 Feb; 29(2):363-70. PubMed ID: 18192686
[TBL] [Abstract][Full Text] [Related]
6. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
[TBL] [Abstract][Full Text] [Related]
7. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
8. Assessment of cellular estrogenic activity based on estrogen receptor-mediated reduction of soluble-form catechol-O-methyltransferase (COMT) expression in an ELISA-based system.
Ho PW; Tse ZH; Liu HF; Lu S; Ho JW; Kung MH; Ramsden DB; Ho SL
PLoS One; 2013; 8(9):e74065. PubMed ID: 24040167
[TBL] [Abstract][Full Text] [Related]
9. Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage.
van Duursen MB; Sanderson JT; de Jong PC; Kraaij M; van den Berg M
Toxicol Sci; 2004 Oct; 81(2):316-24. PubMed ID: 15254334
[TBL] [Abstract][Full Text] [Related]
10. Nordihydroguaiaretic Acid as a Novel Substrate and Inhibitor of Catechol
Kim JH; Lee J; Jeong H; Bang MS; Jeong JH; Chang M
Molecules; 2021 Apr; 26(7):. PubMed ID: 33916785
[TBL] [Abstract][Full Text] [Related]
11. Estrogenic phenol and catechol metabolites of PCBs modulate catechol-O-methyltransferase expression via the estrogen receptor: potential contribution to cancer risk.
Ho PW; Garner CE; Ho JW; Leung KC; Chu AC; Kwok KH; Kung MH; Burka LT; Ramsden DB; Ho SL
Curr Drug Metab; 2008 May; 9(4):304-9. PubMed ID: 18473748
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation.
Goodman JE; Jensen LT; He P; Yager JD
Pharmacogenetics; 2002 Oct; 12(7):517-28. PubMed ID: 12360102
[TBL] [Abstract][Full Text] [Related]
13. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL
Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
[TBL] [Abstract][Full Text] [Related]
14. Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase.
Salama SA; Kamel M; Awad M; Nasser AH; Al-Hendy A; Botting S; Arrastia C
Int J Cancer; 2008 Sep; 123(6):1246-54. PubMed ID: 18566989
[TBL] [Abstract][Full Text] [Related]
15. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
17. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.
Fu J; Weise AM; Falany JL; Falany CN; Thibodeau BJ; Miller FR; Kocarek TA; Runge-Morris M
Breast Cancer Res Treat; 2010 Feb; 120(1):35-45. PubMed ID: 19308726
[TBL] [Abstract][Full Text] [Related]
18. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription.
Xie T; Ho SL; Ramsden D
Mol Pharmacol; 1999 Jul; 56(1):31-8. PubMed ID: 10385681
[TBL] [Abstract][Full Text] [Related]
19. Expression and cyclic variations of catechol-O-methyl transferase in human endometrial stroma.
Salih SM; Salama SA; Fadl AA; Nagamani M; Al-Hendy A
Fertil Steril; 2008 Sep; 90(3):789-97. PubMed ID: 17418156
[TBL] [Abstract][Full Text] [Related]
20. Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney: implications for estrogen-induced renal cancer.
Weisz J; Fritz-Wolz G; Clawson GA; Benedict CM; Abendroth C; Creveling CR
Carcinogenesis; 1998 Jul; 19(7):1307-12. PubMed ID: 9683193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
